The tuberculosis Rv2386c protein, compositions and uses thereof

Details for Australian Patent Application No. 2009273132 (hide)

Owner Glaxo Group Limited GlaxoSmithKline Biologicals s.a.

Inventors Brown, James; Mettens, Pascal; Murphy, Dennis

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009273132

PCT Pub. Number WO2010/010179

Priority 61/083,699 25.07.08 US

Filing date 24 July 2009

Wipo publication date 28 January 2010

International Classifications

C12N 15/60 (2006.01) Mutation or genetic engineering - Lyases (4)

A61K 38/51 (2006.01) Medicinal preparations containing peptides

A61K 38/52 (2006.01) Medicinal preparations containing peptides

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 9/90 (2006.01) Enzymes, e.g. ligases (6.) - Isomerases (5.)

C12N 15/61 (2006.01) Mutation or genetic engineering - Isomerases (5)

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/010179 Priority application(s): WO2010/010179

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009273133-Novel compositions and methods

2009273130-Novel compositions and methods